Article Details

Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for ...

Retrieved on: 2024-09-13 06:15:21

Tags for this article:

Click the tags to see associated articles and topics

Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for .... View article details on hiswai:

Excerpt

SAN DIEGO, Sept. 12, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme") today announced that Roche received U.S. Food and ...

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo